First Trust Nasdaq Pharmaceuticals ETF FTXH | NASDAQ

FTXH last paid $0.0113 a share on Sep 28, and returned 33.6% over 12 months with distributions counted. · 1-year total return +33.6% · Track FTXH in a free portfolio

Dividends

Company Overview:

Market Cap: $1.05B
Trailing PE: N/A
FWD PE: —
Payout Ratio (TTM): —
52-Week Range: $31.83 - $45.10

10 Year FTXH Performance Metrics:

Total Return (with DRIP): 147.5% (9.49% CAGR)
Total Return (no DRIP): 135.3% (8.94% CAGR)
Share Price: 119.5% (8.19% CAGR)
Yield on Cost (with DRIP): 0.27%
Total Invested: $10,000
Total Value (with DRIP): $24,754
Total Return $ (with DRIP): $14,754
Dividend Increase: 68.5% (5.49% CAGR)
Dividend Yield (FWD): 0.11% ($0.05)
FTXH 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
FTXH Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
FTXH Price CAGR:1Y: 32.67%2Y: 23.43%5Y: 9.50%10Y: 8.13%

FTXH Dividend Payments & Yield

Dividend Payments & Yield
FTXH Dividend CAGR:1Y: -92.22%2Y: -69.54%5Y: -22.06%10Y: -10.68%
Annual Dividends (Total Paid Per Year)
Dividend Growth Year Over Year

Compare stocks side-by-side

FTXH Dividends Info:

Annual Dividend: $0.0452
Forward Yield: 0.11%
Ex-Dividend Date: 2026-09-24
Lifetime Dividends / Share: $3.11

Projected Future Returns & Dividends for FTXH

Based on past 10-year performance, here are FTXH growth metrics:

Share price CAGR of +8.13%
Dividend CAGR of -10.69%

Using FTXH CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

FTXH (DRIP)FTXH - No DRIP
Current Price$41.71$41.71
Start Shares239.75239.75
Start Value$10,000$10,000
  
After 10 years:
Final Share Count241.03239.75
Dividends Payment$0.00$0.00
Annual Dividends$4$3
Yield on cost0.04%0.03%
Share Price$91.18$91.18
Total Dividends$69$69
Final Value$21,977$21,929

Estimated Future Value + Dividends - FTXH

NOTE: Above numbers are our estimate based on FTXH's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Company Info

First Trust Nasdaq Pharmaceuticals ETF (FTXH) had its IPO on 2016-09-22, and is traded on NASDAQ stock exchange.

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.

FTXH website: https://www.ftportfolios.com/Retail/Etf/EtfSummary.aspx?Ticker=FTXH


Loading signals…

DCF model unavailable for FTXH — no fundamentals on file (ETFs and funds are not modelable).